Features | Partner Sites | Information | LinkXpress
Sign In
PURITAN MEDICAL
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Ingenuity Systems Acquired by Qiagen, Adding Analysis, Interpretation of Complex Biologic Data Technology

By BiotechDaily International staff writers
Posted on 07 May 2013
Qiagen NV (Hilden, Germany) has acquired Ingenuity Systems, Inc. (Redwood City, CA, USA), a leading provider of biomedical software that effectively analyzes and interprets the biologic meaning of genomic data. Ingenuity has created a curated knowledge system of biomedical data and analysis solutions for the investigation, interpretation, and analysis of complex biologic systems.

New developments such as next-generation sequencing (NGS) are now generating more data in only one year than was generated in all prior history, making the analysis and interpretation of this wide-ranging and very complex biologic data a critical success factor.

At the core of Ingenuity’s product range is the Ingenuity Knowledge Base, a 14-year endeavor to effectively and manually curate, model, and computationally structure the immense amount of biomedical literature, including genomic variations associated with human disease and thousands of disease models. The Ingenuity Knowledge Base and software applications enable users to accurately interpret the significance of increasingly large amounts of biologic data to better direct research and medical treatment decisions.

Ingenuity’s Knowledge Base is constructed on algorithms that pair all human gene variants with biologic interpretations based on known outcomes and discoveries. These pairings are gathered and reviewed by specialists (curated) in a standardized way from a wide range of sources including clinical and scientific publications with the support of advanced technology and refined processes. This process and the associated learning algorithms translate sourced data into interoperable and linkable collections of relevant information.

The Ingenuity product range includes the Ingenuity pathways analysis (IPA) standard web-based software application, which enables researchers to model, analyze, and determine the complex biologic systems at the core of life sciences research. IPA is deployed in most major pharmaceutical companies and hundreds of biotechnology companies and academic institutions globally. It supports data analysis and interpretation from all high-throughput analysis platforms and it is used in virtually all areas of drug discovery and development from target identification and validation to predictive toxicology, biomarkers, and pharmacogenomics.

Ingenuity variant analysis is a web-based NGS data analysis application that solves a vital requirement for researchers trying to rapidly identify relevant causal variants in human diseases in a matter of hours. It enables customers to rapidly identify and prioritize variants by drilling down to a small, targeted subset of compelling variants based upon published biologic evidence and their own knowledge of disease biology. Users can also probe variants from multiple biologic standpoints, examine different biologic theories, and identify the most promising variants for follow-up analysis.

Up to now, thousands of users from leading institutions around the world have already uploaded genomic data using Ingenuity variant analysis, which has been used to analyze more than 45,000 biologic samples. In February 2013, Ingenuity had passed an audit under the US Health Insurance Portability and Accountability Act (HIPAA) and complies with the US-EU Safe Harbor framework.

Ingenuity will substantially expand and strengthen Qiagen’s own curated database, which is embedded in wet lab assays and marketed through Qiagen’s GeneGlobe content portal. GeneGlobe offers hundreds of assay panels for polymerase chain reaction (PCR) and NGS as well as more than 60,000 fully annotated molecular assays for the most sought-after diseases and pathways, curated from the biomedical literature.

Related Links:
Qiagen



Channels

Genomics/Proteomics

view channel
Image: Researchers have generated disease-free stem cells from patients with mitochondrial disease that can be converted into any cell type including neuronal progenitors (left) or heart cells (right). These could potentially be used for future transplantation into patients (Photo courtesy of Salk Institute of Biological Studies).

Methods Developed to Generate Normal Stem Cells from Patients with Mitochondrial Defects

A recent paper described two methods for converting cells from patients with mitochondrial defects into normal pluripotent stem cells that could be induced to differentiate into several different types of tissues.... Read more

Drug Discovery

view channel
Image: A new micelle delivery system for the protective polyphenols resveratrol and quercetin (mRQ) may have value in cancer chemotherapy (Photo courtesy of Oregon State University).

Micelles Containing Resveratrol and Quercetin Reverse Doxorubicin Cardiotoxicity

Cancer researchers blocked the toxic effects of the cancer drug doxorubicin (DOX) by administering it together with the plant antioxidants resveratrol and quercetin. Although in use for more than 40... Read more

Lab Technologies

view channel
Image: The Leica DM2500 LED Microscope for clinical laboratories and research applications (Photo courtesy of Leica Microsystems).

New LED Microscope Completes Line of Clinical and Research Tools

A popular microscope used for both clinical and research applications is now available with LED illumination. The Leica (Wetzlar, Germany) DM2500 and DM2500 LED microscopes represent a class of tools... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.